Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

One 97 Communications Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

The loan distribution partner's assets under management (AUM) excluding the lender that moved away from the DLG (Direct Lending Group) model have shown…

5 Aug 2026

Godrej Consumer Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Volume growth trajectory around 7-8% for the next four quarters after adjusting for GST-related noise. Key concall takeaways from Godrej Consumer's Q2 FY26…

5 Aug 2026

S J S Enterprises Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

New export orders from customers like Autoliv are around INR 5 crores annually per customer. Key concall takeaways from S J S Enterprises Ltd's Q1 FY26…

5 Aug 2026

S J S Enterprises Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

Premiumization is a key growth driver with expanding product portfolios and new generation products now contributing ~28% of revenues (Page 7). Key concall…

5 Aug 2026

FSN E-Commerce Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Beauty vertical continues strong growth at 27-29% year-on-year in GMV and NSV with acceleration noted. Key concall takeaways from FSN E-Commerce's Q3 FY26…

5 Aug 2026

PB Fintech Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Term and health insurance currently make up around half the business, with term growing about 70%. Key concall takeaways from PB Fintech Ltd's Q3 FY26 earnings…

5 Aug 2026

PB Fintech Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

UAE business has turned profitable with 64% YoY premium growth, aligned with Health and Life focus. Key concall takeaways from PB Fintech Ltd's Q2 FY26…

5 Aug 2026

PB Fintech Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

Term insurance grows steadily at 12-15% industry rate; company grows multiples faster than this. Key concall takeaways from PB Fintech Ltd's Q4 FY25 earnings…

5 Aug 2026

Sigachi Industries Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

The API segment has potential revenue of INR 250 crores from Cystic Fibrosis API after 12 months of R&D commercialization. Key concall takeaways from Sigachi…

5 Aug 2026

Sigachi Industries Q2 FY26: Capex ₹60 Cr | Arthneeti

Q2 FY26

The company maintains strong repeat business, with 80-90% repeat customers, suggesting a stable ongoing order inflow. Key concall takeaways from Sigachi…

5 Aug 2026

Aditya Birla Sun Life AMC Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Revenue from operations grew 9% YoY in Q2 FY26 and 12% YoY in H1 FY26, indicating a positive growth trend. Key concall takeaways from Aditya Birla Sun Life AMC…

5 Aug 2026

Aditya Birla Sun Life AMC Q3 FY25 earnings call: Revenue & Margins | Arthneeti

Q3 FY25

Expansion efforts in 25 key locations contributing ~80% of market sales volume. Key concall takeaways from Aditya Birla Sun Life AMC Ltd's Q3 FY25 earnings…

5 Aug 2026

Markolines Pavement Technologies Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Order book stands strong with INR 396 crore unexecuted and a pipeline of INR 600 crore, supporting revenue growth visibility. Key concall takeaways from…

5 Aug 2026

Epigral Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Capex of INR 337 crores spent; ongoing capex plans progressing as per schedule. Key concall takeaways from Epigral Ltd's Q3 FY26 earnings call — and how it…

5 Aug 2026

Epigral Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

. Key concall takeaways from Epigral Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

5 Aug 2026

Epigral Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

450 crore for FY 2026 focused on expanding capacities in CPVC resin (addition of 75,000 tonnes to reach 1,50,000 tonnes) and Epichlorohydrin (expanding from…

5 Aug 2026

Vijaya Diagnostic Centre Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

Price increases contribute approximately 1.5% to 2% of the revenue growth. Key concall takeaways from Vijaya Diagnostic Centre Ltd's Q1 FY26 earnings call…

5 Aug 2026

Vijaya Diagnostic Centre Q3 FY25 earnings call: Revenue & Margins | Arthneeti

Q3 FY25

Wellness segment growth remains strong, contributing about 14% to the top line, with potential seasonal Q4 benefits. Key concall takeaways from Vijaya…

5 Aug 2026

Sansera Engineering Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Q3 revenue increased 25% YoY, highest ever for the company, reflecting strong growth momentum. Key concall takeaways from Sansera Engineering Ltd's Q3 FY26…

5 Aug 2026

Sansera Engineering Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

Order book strong at INR 2,024 crores with more than 60% international orders; adding ~INR 173 crores new orders mainly from ADS and xEV. Key concall takeaways…

5 Aug 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access